Marksans Pharma Limited Share Price & Technical Analysis
MARKSANS · ₹254.8 (+15.68%)
Healthcare / Drug Manufacturers - General
₹254.8
+15.68%
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
38% return in May, 5% avg return in past 3 year May month.
38% return in 2026, 45% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | 3% | -5% | 12% | 38% | – | – | – | – | – | – | – | 38% |
| 25 | -19% | -16% | 7% | -1% | 20% | 1% | -14% | -26% | -3% | 10% | 4% | -4% | -41% |
| 24 | -4% | -2% | -3% | 9% | -10% | 6% | 29% | 13% | 23% | -2% | 16% | -14% | 60% |
| 23 | 10% | 5% | 4% | 14% | 5% | 6% | 30% | -5% | -3% | -4% | 58% | -4% | 116% |
| 22 | -7% | -17% | -3% | 18% | -13% | -8% | 10% | 6% | -11% | 4% | 17% | 0% | -3% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Emerging · Overbought
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹89.91B
P/E ratio
24.96
52W high
₹270.7
52W low
₹155.0
Volume
3,80,50,184
Beta
0.98
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Marksans Pharma Limited share price today?
- Marksans Pharma Limited (MARKSANS) last traded around ₹254.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MARKSANS have?
- StockPro currently tracks 3 active signal(s) for MARKSANS, including breakouts, momentum, and volume patterns. See the signals panel on this page.
- How can I analyze Marksans Pharma Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.